Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockman6767on May 01, 2019 1:35am
127 Views
Post# 29693040

RE:RE:RE:Let's say rights offer is cancelled

RE:RE:RE:Let's say rights offer is cancelledAndjee, what you don't get is that bankruptcy is the BETER option for us and get us much more money than the current restructure that gives it all to SALP. In BK bidders would pay for the entire package much more than the mere $100 million that SALP lent PLI. and that would come to us after repayment of the $100 M loan to the 759 M shares not to 25 BILLION shares! And it wold be an  honest auction to high bidders under the watchful eye of the neutral BK judge.
Bullboard Posts